openPR Logo
Press release

Atopic Dermatitis Market Set for Rapid Expansion (2024-2031): Bayer, Sanofi, Pfizer Inc.

04-24-2025 08:50 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Atopic Dermatitis Market

Atopic Dermatitis Market

The Global Atopic Dermatitis Drugs Market is estimated to reach at CAGR of 4.77% during the forecast period (2024-2031).

Atopic Dermatitis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/atopic-dermatitis-market?rk

The Atopic Dermatitis Market covers treatments for a chronic inflammatory skin condition characterized by itching and rash. Therapeutic options include topical corticosteroids, biologics, and emollients. Increasing prevalence among children and adults boosts demand. Biotech advancements and patient awareness are driving innovation. Regulatory approvals for targeted therapies are transforming treatment paradigms.

List of the Key Players in the Atopic Dermatitis Market:

Bayer, Sanofi, Pfizer Inc., Novartis International AG, Allergan PLC, Abbvie Inc., Meda Pharmaceuticals, JW Pharmaceutical, Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd., Wuhan Disel Biotechnology Co., Ltd., and Qingdao Hiseeking Enterprises Co.

Industry Development:

❁ In August 2018, JW Pharmaceutical entered into a licensing agreement with LEO Pharma A/S regarding JW1601, a novel drug candidate for treating atopic dermatitis. This agreement granted LEO Pharma exclusive rights to develop and commercialize JW1601 worldwide, except for South Korea, where JW Pharmaceutical retains rights. LEO Pharma, known for its leadership in medical dermatology, was poised to bring this promising drug to a broader global market under the agreement. The move is part of JW Pharmaceutical's strategy to expand the reach of its innovative dermatological treatments while partnering with a major industry player in dermatology.

Assessing the Effects of U.S. Tariffs on the Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Atopic Dermatitis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/atopic-dermatitis-market?rk

Segment Covered in the Atopic Dermatitis Market:
By Drug Class: Corticosteroids, Calcineurin Inhibitors, PDE4 inhibitors, Biologics, Other.

By Route of Administration: Topical, Injectable, Oral.

By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.

Regional Analysis for Atopic Dermatitis Market:

The regional analysis of the Atopic Dermatitis Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/atopic-dermatitis-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Atopic Dermatitis market?

➠ Who are the leading manufacturers in the global Atopic Dermatitis industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Atopic Dermatitis industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Atopic Dermatitis market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/atopic-dermatitis-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atopic Dermatitis Market Set for Rapid Expansion (2024-2031): Bayer, Sanofi, Pfizer Inc. here

News-ID: 3985273 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Cell Analysis Market Advances at 3.9% CAGR Driven by Single-Cell Technologies, Precision Medicine & Biopharma R&D
United States Cell Analysis Market Advances at 3.9% CAGR Driven by Single-Cell T …
Leander, Texas and Tokyo, Japan - Jan.12.2026 As per DataM Intelligence research report "cell analysis market reached US$ 64.43 billion in 2023, with a rise of US$ 66.78 billion in 2024, and is expected to reach US$ 94.61 billion by 2033, growing at a CAGR of 3.9% during the forecast period 2025 to 2033." Increasing prevalence of chronic and genetic diseases, adoption of personalized medicine, technological advancements in flow cytometry, high-content
Japan AI Accelerator Chip Market Surges at 33.19% CAGR Driven by Generative AI, Hyperscale Cloud & Edge Computing
Japan AI Accelerator Chip Market Surges at 33.19% CAGR Driven by Generative AI, …
Leander, Texas and Tokyo, Japan - Jan.12.2026 As per DataM Intelligence research report "AI Accelerator Chip Market reached US$ 28.59 billion in 2024 and is expected to reach US$ 283.13 billion by 2032, growing with a CAGR of 33.19% from 2025 to 2032." Explosive adoption of Generative AI, natural language processing (NLP), autonomous systems, advanced computer vision, government investments in AI hardware, and integration in edge/cloud computing are fueling growth in
Japan Rolled Aluminum Products Market | 7.59% CAGR | EVs, Packaging & Sustainable Aluminum Drive Demand
Japan Rolled Aluminum Products Market | 7.59% CAGR | EVs, Packaging & Sustainabl …
Leander, Texas and Tokyo, Japan - Jan.12.2026 As per DataM Intelligence research report "Rolled Aluminum Products Market reached US$ 45,353.76 million in 2024 and is expected to reach US$ 80,765.72 million by 2032, growing with a CAGR of 7.59% from 2025 to 2032." Rising demand from automotive (especially EVs for lightweighting), construction, packaging industries due to aluminum's lightweight, corrosion resistance, recyclability, along with sustainability trends toward low-carbon and recycled aluminum, and
Japan Chromatography Market Grows at 5.7% CAGR as HPLC/UHPLC, MS Integration & Biopharma Quality Demands Accelerate Adoption
Japan Chromatography Market Grows at 5.7% CAGR as HPLC/UHPLC, MS Integration & B …
Leander, Texas and Tokyo, Japan - Jan.12.2026 As per DataM Intelligence research report "Chromatography Market reached US$ 10.65 billion in 2024 and is expected to reach US$ 17.51 billion by 2033, growing with a CAGR of 5.7% from 2025 to 2033." Increasing demand for pharmaceutical and biopharmaceutical analysis, advancements in analytical technologies like HPLC/UHPLC and mass spectrometry integration, regulatory compliance requirements, and expansion in R&D, environmental monitoring, food safety, and clinical

All 5 Releases


More Releases for Atopic

Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Atopic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The scope of the atopic dermatitis market has experienced substantial expansion recently, projected to increase from $8.61 billion in 2024 to reach $9.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.7%;
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Atopic Dermatitis Market Size By 2025? The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Atopic Dermatitis Pipeline
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029. Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an